Literature DB >> 6801130

Evidence that antisera that react with products of the human HLA-DR locus may block in vitro antigen-induced proliferation by inducing suppression.

A V Muchmore, J M Decker, D L Mann.   

Abstract

It is widely recognized that antisera that interact with determinants encoded by the Ia region of the mouse and its counterpart, the DR locus of man, are capable of interfering with the ability of monocytes and lymphocytes to respond in vitro to an antigenic stimulus. Using an in vitro assay that measures antigen-specific proliferation of human lymphocytes, we found that both a heteroantiserum raised in rabbits (anti-P29,34) and alloantisera which recognize determinants encoded for by the human DR locus dramatically block in vitro antigen-specific proliferation. These anti-DR antisera appear to act at the level of the monocyte; monocytes pulsed and washed free of excess antisera fail to promote proliferation in the presence of soluble antigen and untreated T cells whereas identically pulsed and washed T cells respond normally with untreated monocytes. Furthermore, the addition of unpulsed monocytes fails to restore in vitro antigen-specific reactivity. Our data suggest that membrane-bound anti-DR-specific antisera on monocytes is profoundly suppressive, and also suggests simple steric hindrance may not account for all of the observed effects such antisera have on monocyte-T cell interactions.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6801130

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

Review 1.  The function of lymphocytes in normal and suppressed hematopoiesis.

Authors:  N Zoumbos; P Gascon; N Young
Journal:  Blut       Date:  1984-01

2.  The role of products of the human HLA-DR locus (Ia molecules) in in vitro M. leprae driven lymphoproliferation.

Authors:  A Haregewoin; T Yemaneberhan; A Belehu
Journal:  Clin Exp Immunol       Date:  1983-08       Impact factor: 4.330

3.  HLA-DR histocompatibility leukocyte antigens permit cultured human melanoma cells from early but not advanced disease to stimulate autologous lymphocytes.

Authors:  D Guerry; M A Alexander; M F Herlyn; L M Zehngebot; K F Mitchell; C M Zmijewski; E J Lusk
Journal:  J Clin Invest       Date:  1984-01       Impact factor: 14.808

4.  Regulation of human peripheral blood monocyte DR antigen expression in vitro by lymphokines and recombinant interferons.

Authors:  M B Sztein; P S Steeg; H M Johnson; J J Oppenheim
Journal:  J Clin Invest       Date:  1984-02       Impact factor: 14.808

5.  Allogeneic suppressive effects of pregnancy sera on monocytes of responding cells in human mixed lymphocyte reactions.

Authors:  M Nieda; T Juji; S Imao
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

6.  Antigen-specific HLA-restricted human T-cell lines. II. A GAT-specific T-cell line restricted by a determinant carried by an HLA-DQ molecule.

Authors:  E J Ball; P Stastny
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

7.  Treatment of (NZB x NZW)F1 disease with anti-I-A monoclonal antibodies.

Authors:  N E Adelman; D L Watling; H O McDevitt
Journal:  J Exp Med       Date:  1983-10-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.